Association of 5-hydroxytryptamine 3 receptor antagonists with prognosis in patients with advanced hepatocellular carcinoma: A propensity score-matched study

Xiaoge Zhang, Xiaoyun Wang, Na Li, Qunying Han, Zhengwen Liu · 2026

Read Association of 5-hydroxytryptamine 3 receptor antagonists with prognosis in patients with advanced hepatocellular carcinoma: A propensity score-matched study by Xiaoge Zhang, Xiaoyun Wang, Na Li, Qunying Han, Zhengwen Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0359798.txt.

Description

Xiaoge Zhang, Xiaoyun Wang, Na Li, Qunying Han, and Zhengwen Liu published this research article in PLOS ONE in 2026. It concerns advanced hepatocellular carcinoma, the most common type of liver cancer. The authors examine a group of drugs called 5-hydroxytryptamine 3 receptor antagonists, often used against nausea, and their link to patient prognosis.

To make the comparison fair, the team used propensity score matching, which pairs similar patients who did or did not receive these drugs. That design tries to separate the drug's association from other differences between patients. Oncologists may find the result useful when supportive-care drugs are chosen for people with advanced liver cancer.

Catalog record

CREATORXiaoge Zhang, Xiaoyun Wang, Na Li, Qunying Han, Zhengwen Liu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38806
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0359798

Browse the full library · About the Tower of Babel